Related references
Note: Only part of the references are listed.Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014
Arpan Patel et al.
HEPATOLOGY INTERNATIONAL (2016)
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
Shigeru Kusumoto et al.
CLINICAL INFECTIOUS DISEASES (2015)
Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral Prophylaxis
Chih-An Shih et al.
PLOS ONE (2015)
Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy A Randomized Clinical Trial (vol 312, pg 2521, 2014)
He Huang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study
Wai-Kay Seto et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Perception of hepatitis B virus infection reactivation-related issues among specialists managing hematologic malignancies: result of an Italian survey
Massimo Marignani et al.
LEUKEMIA & LYMPHOMA (2014)
Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy A Randomized Clinical Trial
He Huang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group
Seok Jin Kim et al.
EUROPEAN JOURNAL OF CANCER (2013)
Testing for hepatitis B infection in prospective chemotherapy patients: A retrospective study
Ying Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection
Nada Kanaan et al.
JOURNAL OF CLINICAL VIROLOGY (2012)
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
A. M. Evens et al.
ANNALS OF ONCOLOGY (2011)
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT
M. Vigano et al.
BONE MARROW TRANSPLANTATION (2011)
Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy Analysis of 257 Cases
Roberto Perez-Alvarez et al.
MEDICINE (2011)
Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell Transplantation
Sarah P. Hammond et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma
Shigeru Kusumoto et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab
Winnie Yeo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Systematic review: The effect of preventive lamivudine on hepatitis B reactivation during chemotherapy
Rohit Loomba et al.
ANNALS OF INTERNAL MEDICINE (2008)
Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection
M Onozawa et al.
TRANSPLANTATION (2005)
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy
W Yeo et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
AL Cheng et al.
HEPATOLOGY (2003)